SCHEMBL4790

SCHEMBL4790

CCN(c1cc(-c2ccccc2)no1)c1c(C)noc1-c1ccc(-c2ccc(C3(CC(=O)O)CC3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.34
ABCC3 O15438 1/20 0.34
ABCC4 O15439 1/20 0.34
ABCB11 O95342 1/20 0.34
CYP2C8 P10632 1/20 0.34
CYP2C9 P11712 1/20 0.34
ABCB4 P21439 1/20 0.34
LPAR1 Q92633 1/20 0.34
ABCC2 Q92887 1/20 0.34
SLCO1B3 Q9NPD5 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
ALDH1A1 P00352 5/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
IP6K1 Q92551 3/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.33
UCHL1 P09936 1/20 0.33
USP30 Q70CQ3 1/20 0.33
USP2 O75604 2/20 0.32
HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4089 0.92 BRD4 (0.39) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7222 0.84 ABCC3 (0.34) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6411 0.81 BRD4 (0.33) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL13530 0.76 LPAR1 (0.45) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6641 0.75 GAA (0.37) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL4791 0.75 ALDH1A1 (0.42) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7534 0.72 L3MBTL1 (0.34) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL3954 0.72 LPAR1 (0.43) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7234 0.71 LPAR1 (0.34) BRD4ABCC3ABCC4ABCB11CYP2C8
SCHEMBL4734 0.71 ABCC3 (0.37) BRD4ABCC3ABCC4ABCB11CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP claimed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO claimed
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed